Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA.
about
Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanismsGuarding the perimeter: protection of the mucosa by tissue-resident memory T cellsFoot-and-mouth disease virus persists in the light zone of germinal centresA viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.Characterization of a single-cycle rabies virus-based vaccine vector.Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.Agonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection.Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector.Interferon-induced protein Ifit2 protects mice from infection of the peripheral nervous system by vesicular stomatitis virus.Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis.Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.Persistent antigen presentation after acute vesicular stomatitis virus infectionInterferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.A chimeric vesiculo/alphavirus is an effective alphavirus vaccineQuantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo.Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin.Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.Sustained antigen availability during germinal center initiation enhances antibody responses to vaccinationViruses - from pathogens to vaccine carriersLentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.Vesicular stomatitis virus genomic RNA persists in vivo in the absence of viral replication.Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain.Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.Cold-adapted influenza viruses as a promising platform for viral-vector vaccines.Role of peripheral immune response in microglia activation and regulation of brain chemokine and proinflammatory cytokine responses induced during VSV encephalitis.Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
P2860
Q24302747-5FAD3503-C19F-422A-92A8-15C09D146392Q26822643-40E7B864-76B2-4713-B1D5-6772F084555AQ27438168-E6906BA5-0B10-4663-BF56-F33CAF4E0A2CQ30370147-EA3569F2-95F7-494B-AF07-F7EC10CF3200Q33653655-5869C66B-34EE-4557-BE24-F4E80930448BQ33676502-845505DF-B93C-4CDA-B53B-9298EAD23E0CQ33743852-D256953B-AF11-4B90-AED5-7919D71E8448Q34105274-1D8689D6-F5D3-4058-88AE-DE87AA9118AAQ34262131-AEF30C36-A002-46C1-B47D-242CB341E0C8Q34262291-BF7E416E-D6FC-4154-8543-5EBF53416CE1Q34277052-044EEF2A-8D3C-4990-9FC2-0699CD0D67CCQ35009470-E4765543-EB70-4BAE-92A4-D0C111D46AAEQ35635383-F6B5A2FF-6B8A-4432-9B78-426517EEE70DQ35861186-D26D3675-A0EC-4C08-A7CA-FDC281E07FF3Q36506753-A9C2D293-A260-4AF6-B874-81409156E218Q36580773-8832A029-B02E-4CCA-9EC4-DC8204F2BB8DQ36665882-CFDDFA14-0FE8-4723-AF16-5474AA3F142AQ36898706-790E692C-1779-4112-BF85-C3DCA1B1234CQ37354600-4DF19A2C-9115-4405-9864-17D86F05DDB2Q37379662-60EC9CE0-1758-40DD-87AC-C1F433BE6DE8Q37946370-A957FCE9-5E1E-4F6C-BBF2-DAF5AEAEE7AEQ39511106-F241E0E6-74AE-4A28-B25C-23372ACED046Q39610541-C95A1B68-BF43-499C-92DB-D2BFC3B0BF17Q39804428-0B26DA12-3806-4618-92B4-11BF48EEF52CQ40039979-CC179FA0-8B51-49CA-A288-5EEEB3D284A4Q40664205-5B5EE606-28A9-4EF6-B81A-EF2E0DD0E7DBQ41981639-4204098A-B698-4644-AD75-9C9B19E90B8EQ42795549-EF413E82-2BB2-45D0-92C0-2F3E8418A491Q47322109-2E86EF08-508C-4C9C-8E2C-C57C08693036
P2860
Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Replication and propagation of ...... nd persistence of genomic RNA.
@en
Replication and propagation of ...... nd persistence of genomic RNA.
@nl
type
label
Replication and propagation of ...... nd persistence of genomic RNA.
@en
Replication and propagation of ...... nd persistence of genomic RNA.
@nl
prefLabel
Replication and propagation of ...... nd persistence of genomic RNA.
@en
Replication and propagation of ...... nd persistence of genomic RNA.
@nl
P2093
P2860
P356
P1433
P1476
Replication and propagation of ...... nd persistence of genomic RNA.
@en
P2093
Ian D Simon
Jean Publicover
John K Rose
P2860
P304
P356
10.1128/JVI.02525-06
P407
P577
2006-12-06T00:00:00Z